FDA Class II Medical Device Regulations and Compliance

Jenn Dixon

October 3, 2024

Table of Contents

• FDA Class II Medical Device Regulations and Compliance
• How to be Compliant with Premarket Submission Requirements for Class II Medical Devices
• How to Submit Class II Medical Device Premarket 510(k) and De Novo Classification Request
• 510(k) and De Novo Exempt Class I and Class II Medical Devices
• Class II Medical Device Quality System Regulation (QSR) Compliance
• Post-Market Surveillance and Reporting Regulations for Class II Medical Devices
• How Ketryx Can help Manufacturers with Class II Medical Device Life Cycle

FDA Class II Medical Device Regulations and Compliance

Class II medical devices are defined by their moderate-to-high risk profile. According to 2017 data from the FDA, these medical devices, such as powered wheelchairs or contact lenses, consist of 43% of medical device applications. With some exceptions, Class II medical devices are required to submit a premarket 510(k) or De Novo request due to the importance of demonstrating safety and effectiveness. This in-depth guide will provide manufacturers with a comprehensive understanding of the regulatory complexities surrounding Class II medical devices. We'll define and provide examples of Class II medical devices, adhere to the premarket submission process, Quality System Regulation (QSR) compliance, and post-market responsibilities.

What is a Class II Medical Device?

A Class II medical device is a category of medical devices defined by the U.S. Food and Drug Administration (FDA) as those that require more regulatory controls to provide reasonable assurance of their safety and effectiveness, compared to Class I devices. Class II devices are typically higher risk than Class I but do not require the extensive premarket approval (PMA) process that Class III devices require.

Class II Medical Device Examples

Examples of a Class II medical device include:

• Powered Wheelchairs
• Infusion Pumps
• Surgical Drapes
• Ultrasound Diagnostic Equipment
• MRI Machines
• Air Purifiers for Medical Use
• Dental Amalgamators
• Condoms
• Contact Lenses
• Hearing Aids
• Catheters

How to be Compliant with Premarket Submission Requirements for Class II Medical Devices

The FDA requires a majority of manufacturers of Class II medical devices to submit the 510(k) or De Novo premarket notification. However, there are some Class II medical devices that are exempt from these premarket submissions. See the FDA's website for an up to date list.

The 510(K) premarket submission is for manufacturers to demonstrate that a proposed device is substantially equivalent to a legally marketed predicate device. Substantial equivalence implies that the new device is at least as safe and effective as the predicate, sharing similar intended use and technological characteristics, or presenting the same intended use with different technological characteristics without raising new questions of safety or efficacy. The De Novo premarket submission is less common and is required when a device does not have a substantially equivalent predicate device.

Key Components of a 510(k) Submission:

• Cover Letter: Provides an introduction and overview of the submission, including the type of 510(k) notice, the submitter's information, and a brief description of the device.
• 510(k) Summary or 510(k) Statement: A summary is a brief overview of the submission, including the device name, use, comparisons with predicate devices, and conclusions about substantial equivalence. Alternatively, a 510(k) statement declares that the submitter will make safety and effectiveness information available to interested parties upon request. It is important to note that this information will be made public.
• Indications for Use Statement: A precise description of what the device is used for and how it is to be used.
• Device Description: Detailed information about the device including its technical parameters, features, components, and materials. This section also typically includes a comparison of the new device to the predicate device(s).
• Substantial Equivalence Discussion: This is a critical section where the submitter must demonstrate that the device is as safe and effective as the legally marketed predicate. This includes detailed comparisons in terms of design, materials, energy source, mechanical features, and other characteristics.
• Proposed Labeling: Includes the draft labeling, instructions for use, and any promotional materials for the device. The FDA reviews this to ensure that it is appropriate and not misleading.
• Sterilization and Shelf Life: For devices that are sterilized, detailed information on the sterilization process, validation, and stability of the device over its proposed shelf life must be included.
• Biocompatibility: If the device is intended to have contact with the body, data on biocompatibility testing as per ISO 10993-1 is required to ensure that the device does not induce a harmful response in the body.
• Software Documentation: If the device includes software or is computer-controlled, the submission must include documentation on software development and validation that matches the software's risk level. It should also contain details about any information, prompts, and warnings the system displays. Additionally, the software documentation must substantiate all claims related to performance and safety. The FDA has provided guidance documents on the recommended documentation requirements for premarket submission: OTS Software Use in Medical Devices, Cybersecurity for Networked Medical Devices with OTS Software, General Principles of Software Validation.
• Performance Testing: Includes both non-clinical (bench) and possibly clinical performance data demonstrating that the device performs as intended. This can include mechanical, electrical safety, electromagnetic compatibility, and other relevant testing.
• Electromagnetic Compatibility and Electrical Safety: Information and testing data to show the device operates safely in its intended environments, including issues related to electromagnetic disturbances that could impact device performance.
• Quality System Information: Evidence that the device is manufactured under a quality system compliant with FDA’s quality system regulations. Although full Quality System Regulation documentation is not required in the submission, the FDA may inspect the facility to verify compliance.
• Financial Certification or Disclosure Statement: Required for certain submissions to disclose any financial arrangements between sponsors and clinical study investigators.

Key Components of a De Novo Submission:

• Device Description: Detailed information about the device, including its intended use, indications, technical aspects, and how it operates.
• Classifications and Codes: Identification of the product code, regulation number, and proposed classification (typically Class I or II) that defines the regulatory category for the device.
• Regulatory Information: A statement explaining why the De Novo pathway is appropriate, including an analysis of why the device is not substantially equivalent to any existing devices.
• Risk Analysis: An assessment of the potential risks and benefits associated with the use of the device. This should include a risk management plan detailing how identified risks are mitigated.
• Non-clinical and Clinical Data: Depending on the device and its intended use, non-clinical (lab testing, bench tests, animal studies) and clinical data (human trials) may be required to demonstrate safety and effectiveness.
• Labeling: Proposed labeling, packaging, and user instructions that ensure safe use of the device. This includes any warnings, precautions, and contraindications.
• Quality System Information: Documentation that the manufacturing processes meet the FDA’s Quality System Regulation (QSR) requirements. This typically includes details on design controls, production and process controls, and quality assurance.
• Comparative Analyses: If applicable, comparative analyses with similar devices (despite the lack of substantial equivalence) to provide context and support for safety and effectiveness claims.
• Performance Standards and Testing: Description of how the device meets relevant performance standards and the results of any performance testing conducted.
• Other Supporting Information: Any other documentation that supports the application, such as bibliographies of published literature related to the device, summaries of research findings, and letters of support from scientific communities.

Successfully navigating the 510(k) or De Novo process requires a strategic approach, meticulous documentation, and often, engagement with the FDA through pre-submission meetings to clarify submission requirements and expectations.

How to Submit Class II Medical Device Premarket 510(k) and De Novo Classification Request

Recently the FDA changed the way that manufacturers are allowed to submit 510(k)s and De Novo requests. Before this change, companies had to either mail in a USB or physical paperwork containing their 510(k) or De Novo request. As of October, 2023, all companies must send a 510(k) or De Novo request with an electronic copy (eCopy) or electronic Submission Template and Resource (eSTAR) through the CDRH Customer Collaboration Portal (CDRH Portal).

510(k) and De Novo Exempt Class I and Class II Medical Devices

The FDA has created a list of Class I and Class II medical devices that can be exempt from premarket notification requirements, such as the 510(k) and De Novo submission. Although subjected to certain limitations, the list of exempt premarket notification requirements for Class I and Class II medical devices includes:

• General Biological Products Standards
• Additional Standards for Diagnostic Substances for Laboratory Tests
• Clinical Chemistry and Clinical Toxicology Devices
• Hematology and Pathology Devices
• Immunology and Microbiology Devices
• Anesthesiology Devices
• Cardiovascular Devices
• Dental Devices
• Ear, Nose, and Throat Devices
• Gastroenterology-Urology Devices
• General and Plastic Surgery Devices
• General Hospital and Personal Use Devices
• Neurological Devices
• Obstetrical and Gynecological Devices
• Ophthalmic Devices
• Orthopedic Devices
• Physical Medicine Devices
• Radiology Devices

For each of these categories, there are subclasses which are not exempt from premarket notification requirements. Manufacturers need to do their own research in order to designate whether or not their specific product falls under these exemptions.

Class II Medical Device Quality System Regulation (QSR) Compliance

Compliance with the Quality System Regulation (21 CFR Part 820) is mandatory for Class II device manufacturers, establishing a comprehensive framework for the design, production, labeling, and distribution of medical devices. The QSR emphasizes a process-oriented approach to quality management, ensuring that devices are consistently produced to meet specified requirements and regulatory standards.

Critical Elements of QSR Compliance:

• Design Controls: Systematic measures during device design to ensure that product specifications meet user needs and intended use(s).
• Production and Process Controls: Standardized manufacturing processes that ensure the device is produced according to predetermined specifications.
• Corrective and Preventive Actions (CAPA): Mechanisms for identifying, documenting, and correcting defects and nonconformities, as well as preventing their recurrence.
• Document Controls and Record Keeping: Rigorous documentation processes for maintaining traceability and accountability throughout the device's lifecycle.

Adherence to QSR is not just about regulatory compliance; it's a commitment to quality that enhances device safety and reliability, fostering trust among consumers and healthcare professionals.

Post-Market Surveillance and Reporting Regulations for Class II Medical Devices

After a Class II device enters the market, manufacturers are obligated to engage in vigilant post-market surveillance (PMS) to monitor the device's performance and identify potential safety issues. PMS activities are critical for early detection of adverse events and the implementation of necessary corrective actions to protect public health.

Key Post-Market Responsibilities:

• Medical Device Reporting (MDR): Mandatory reporting of adverse events that could lead to death or serious injury, or if the device malfunctioned in a way that would likely cause or contribute to a death or serious injury if the malfunction were to recur.
• Recalls and Field Safety Corrective Actions: Procedures for removing or correcting marketed devices that violate FDA laws or pose a risk to health.
• Post-Market Studies: In some cases, the FDA may require post-market studies to further assess a device's safety and effectiveness under real-world conditions.

How Ketryx Can help Manufacturers with Class II Medical Device Life Cycle

For manufacturers of Class II medical devices, navigating the regulatory environment is a complex but manageable journey with careful planning, comprehensive understanding, and strategic engagement with regulatory processes. Ketryx helps manufacturers with aspects of the initial 510(k) or De Novo submission such as the benefits and risk control measure, software documentation and cybersecurity section. Ketryx is also able to create documentation and plans to ensure manufacturers are QSR and postmarket surveillance-compliant. Ketryx’s automatic evidence generation frees up manufacturers from hours of tedious and error-prone work - allowing them to focus on quality, safety, and efficacy to successfully bring their innovations to market and ensure their continued success in improving patient care.

Ketryx also is able to take the burden off of manufacturers when it comes to labeling specifications for their Class II medical device software by using a systems of systems model - extracting out any labeling requirements from the rest of the software device, making sure that the labeling requirements are fulfilled per the V&V cycle.